Search results

''IRVINE, CALIF., July 20, 2004 -- Allergan Inc. announced that the FDA has approved Botox (botulinum toxin type A) for the treatment of severe primary axillary hyperhidrosis (severe underarm sweating) that is inadequately managed with topical agents.'' 8 years later in Australia Medicare has...